BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma V, Mandavdhare HS, Lamoria S, Singh H, Kumar A. Serial C-reactive protein measurements in patients treated for suspected abdominal tuberculosis. Dig Liver Dis 2018;50:559-62. [PMID: 29301734 DOI: 10.1016/j.dld.2017.12.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Sharma V. Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis. Expert Rev Gastroenterol Hepatol 2020;14:647-50. [PMID: 32552311 DOI: 10.1080/17474124.2020.1785870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Dawra S, Mandavdhare HS, Singh H, Prasad KK, Dutta U, Sharma V. Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis. Clin Exp Hepatol 2019;5:60-4. [PMID: 30915408 DOI: 10.5114/ceh.2019.83158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Bellam BL, Mandavdhare HS, Sharma K, Shukla S, Soni H, Kumar-M P, Singh H, Prasad KK, Dutta U, Sharma V. Utility of tissue Xpert-Mtb/Rif for the diagnosis of intestinal tuberculosis in patients with ileocolonic ulcers. Ther Adv Infect Dis 2019;6:2049936119863939. [PMID: 31431826 DOI: 10.1177/2049936119863939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kumar NP, Moideen K, Bhootra Y, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity. Immunology 2019;156:249-58. [PMID: 30427060 DOI: 10.1111/imm.13023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Sharma V, Singh H, Mandavdhare HS. Defining 'Satisfactory Response' to Therapy in Abdominal Tuberculosis: A Work in Progress. Infect Disord Drug Targets 2020;20:111-4. [PMID: 30345933 DOI: 10.2174/1871526518666181022111323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Krishnamurthy G, Rajendran J, Sharma V, Kumar H, Singh H. Incidental peritoneal tuberculosis: surgeon's dilemma in endemic regions. Ther Adv Infect Dis 2018;5:97-102. [PMID: 30224953 DOI: 10.1177/2049936118783687] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Cho JK, Choi YM, Lee SS, Park HK, Cha RR, Kim WS, Kim JJ, Lee JM, Kim HJ, Ha CY, Kim HJ, Kim TH, Jung WT, Lee OJ. Clinical features and outcomes of abdominal tuberculosis in southeastern Korea: 12 years of experience. BMC Infect Dis 2018;18:699. [PMID: 30587154 DOI: 10.1186/s12879-018-3635-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
8 Goyal P, Shah J, Gupta S, Gupta P, Sharma V. Imaging in discriminating intestinal tuberculosis and Crohn’s disease: past, present and the future. Expert Review of Gastroenterology & Hepatology 2019;13:995-1007. [DOI: 10.1080/17474124.2019.1673730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Kattan J, Haddad FG, Menassa-Moussa L, Kesrouani C, Daccache S, Haddad FG, Atallah D. Peritoneal Tuberculosis: A Forsaken Yet Misleading Diagnosis. Case Rep Oncol Med 2019;2019:5357049. [PMID: 31781444 DOI: 10.1155/2019/5357049] [Reference Citation Analysis]
10 Kathamuthu GR, Moideen K, Kumar NP, Sridhar R, Baskaran D, Babu S. Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment. PLoS One 2020;15:e0233426. [PMID: 32470023 DOI: 10.1371/journal.pone.0233426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mandavdhare HS, Singh H, Dutta U, Sharma V. A real-world experience with 6 months of antitubercular therapy in abdominal tuberculosis. JGH Open 2019;3:201-5. [PMID: 31276036 DOI: 10.1002/jgh3.12136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hammami F, Ben Ayed H, Koubaa M, Chakroun A, Hsairi M, Smaoui F, Gargouri L, Rekik K, Ben Jemaa M. Clinical, laboratory and evolutionary features of abdominal tuberculosis in comparison with other forms of extrapulmonary tuberculosis. Indian Journal of Tuberculosis 2021. [DOI: 10.1016/j.ijtb.2021.07.017] [Reference Citation Analysis]
13 Chen P, Zhou G, Lin J, Li L, Zeng Z, Chen M, Zhang S. Serum Biomarkers for Inflammatory Bowel Disease. Front Med (Lausanne). 2020;7:123. [PMID: 32391365 DOI: 10.3389/fmed.2020.00123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
14 Singh A, Sahu MK, Panigrahi M, Behera MK, UthanSingh K, Kar C, Narayan J. Abdominal tuberculosis in Indians: Still very pertinent. J Clin Tuberc Other Mycobact Dis 2019;15:100097. [PMID: 31720424 DOI: 10.1016/j.jctube.2019.100097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
15 Vithoosan S, Shanjeeban P, Anpalahan JP, Piranavan P, Karunatilake H, Jayanaga A. A Rare Cause of Ascites-Disseminated TB with Peritonitis in a Middle-Aged Female. Case Rep Gastrointest Med 2019;2019:5076857. [PMID: 31240138 DOI: 10.1155/2019/5076857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Jena A, Jha DK, Sharma V. Distinguishing intestinal tuberculosis from Crohn's disease. Lancet Gastroenterol Hepatol 2021;6:159. [PMID: 33581752 DOI: 10.1016/S2468-1253(20)30364-2] [Reference Citation Analysis]
17 Awad A, Pampiglione T, Ullah Z. Abdominal tuberculosis with a Pseudo-Sister Mary Joseph nodule mimicking peritoneal carcinomatosis. BMJ Case Rep 2019;12:e229624. [PMID: 31217214 DOI: 10.1136/bcr-2019-229624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Eraksoy H. Gastrointestinal and Abdominal Tuberculosis. Gastroenterol Clin North Am 2021;50:341-60. [PMID: 34024445 DOI: 10.1016/j.gtc.2021.02.004] [Reference Citation Analysis]
19 Agarwala R, Singh AK, Shah J, Mandavdhare HS, Sharma V. Ileocecal thickening: Clinical approach to a common problem. JGH Open 2019;3:456-63. [PMID: 31832544 DOI: 10.1002/jgh3.12186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Fusani L, Tersigni C, Chiappini E, Venturini E, Galli L. Old biomarkers in tuberculosis management: are they still useful? a systematic review. Expert Rev Anti Infect Ther 2021;:1-13. [PMID: 33722116 DOI: 10.1080/14787210.2021.1898945] [Reference Citation Analysis]
21 Shukla J, Jena A, Singh H, Mandavdhare HS, Dutta U, Sharma V. Management of gastrointestinal tuberculosis during COVID pandemic: Lessons for posterity. Digestive and Liver Disease 2021;53:394-6. [DOI: 10.1016/j.dld.2020.11.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sharma V, Verma S, Kumar-m P, Mandavdhare HS, Singh H, Shah J, Kalsi D, Dutta A, Mishra S, Prasad KK, Sharma AK, Dutta U. Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn’s disease in patients started on antitubercular therapy. European Journal of Gastroenterology & Hepatology 2021;33:334-8. [DOI: 10.1097/meg.0000000000001879] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Lal SB, Bolia R, Menon JV, Venkatesh V, Bhatia A, Vaiphei K, Yadav R, Sethi S. Abdominal tuberculosis in children: A real-world experience of 218 cases from an endemic region. JGH Open 2020;4:215-20. [PMID: 32280767 DOI: 10.1002/jgh3.12245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ahamed Z R, Shah J, Agarwala R, Kumar-m P, Mandavdhare HS, Gupta P, Singh H, Sharma A, Dutta U, Sharma V. Controversies in classification of peritoneal tuberculosis and a proposal for clinico-radiological classification. Expert Review of Anti-infective Therapy 2019;17:547-55. [DOI: 10.1080/14787210.2019.1642746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
25 Sharma V, Jha DK, Rohilla M, Das CK, Singh H, Irrinki S, Arora A, Saha SC, Gupta P, Mandavdhare HS, Dutta U, Sharma A. 'Rollover' abdominal paracentesis versus standard technique: protocol of a crossover randomized comparative trial. Future Oncol 2021;17:3425-31. [PMID: 34156308 DOI: 10.2217/fon-2020-1050] [Reference Citation Analysis]
26 Ma L, Zhu Q, Li Y, Li W, Wang X, Liu W, Li J, Jiang Y. The potential role of CT enterography and gastrointestinal ultrasound in the evaluation of anti-tubercular therapy response of intestinal tuberculosis: a retrospective study. BMC Gastroenterol 2019;19:106. [PMID: 31242849 DOI: 10.1186/s12876-019-1030-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sharma V, Soni H, Kumar-M P, Dawra S, Mishra S, Mandavdhare HS, Singh H, Dutta U. Diagnostic accuracy of the Xpert MTB/RIF assay for abdominal tuberculosis: a systematic review and meta-analysis. Expert Rev Anti Infect Ther 2021;19:253-65. [PMID: 32845790 DOI: 10.1080/14787210.2020.1816169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]